# BUPIVACAINE HYDROCHLORIDE
> **ANDA207266** · Abbreviated New Drug Application (Generic) · Sponsor: BAXTER HLTHCARE CORP · Approved 2016-07-25
## Drug
- **FDA Application Number:** ANDA207266
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** BUPIVACAINE HYDROCHLORIDE
- **Generic name:** Bupivacaine Hydrochloride
- **Active ingredients:** BUPIVACAINE HYDROCHLORIDE
- **Dosage form:** INJECTABLE
- **Route:** SPINAL
- **Marketing status:** Discontinued
- **Sponsor:** BAXTER HLTHCARE CORP
- **First approval:** 2016-07-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207266)
---
*AI Analytics · CC0 1.0*